Latest Eli Lilly and Company News & Updates

See the latest news and media coverage for Lilly. We track all announcements, press releases, and industry mentions in real time, all in one place.

Eli Lilly and Company (Lilly)

Global biopharmaceutical company

lilly.com

Headquarters: Indianapolis, United States
Company type: Public company
Number of employees: 55,000+

Last updated Today

Latest news about Eli Lilly and Company (Lilly)

In short: Lilly continued its expansion into obesity and Alzheimer's markets while facing regulatory friction and clinical setbacks in Europe and the US.

Company announcements

June 22 Lilly

Lilly declares a third-quarter 2026 dividend

The board declared $1.73 per share, payable on September 10, 2026.

June 14 Lilly

Lilly's Jaypirca reduces disease progression risk by 45%

Phase 3 BRUIN CLL-322 trial met primary endpoint with significant PFS improvement in previously treated CLL/SLL.

June 9 Lilly

Lilly announces FDA approval of EBGLYSS for every-eight-week maintenance dosing

The approval allows patients with moderate-to-severe atopic dermatitis to receive injections as few as six times per year without mandatory topicals.

June 8 Lilly

Lilly's Foundayo shows superior A1C control

Three Phase 3 ACHIEVE trials showed greater A1C reduction and weight loss versus oral semaglutide, dapagliflozin, and placebo; Lilly plans FDA submission by end of Q2 2026.

Media coverage

Yesterday Seeking Alpha

Eli Lilly eyes European launch of obesity pill in H2 2026 or early 2027

Eli Lilly (LLY) stock is in focus as the company plans to launch the weight-loss pill orforglipron in Europe and Great Britain in H2 2026...

Yesterday Yahoo Finance

Eli Lilly says Trump pricing policy will affect obesity drug launches in Europe

By Maggie Fick BRUSSELS, June 23 (Reuters) - Eli Lilly expects to launch its weight-loss pill in...

Yesterday New York Magazine

Did Trump Get Early Access to Eli Lilly's New Weight-Loss Drug?

The FDA let one 79-year-old take an experimental obesity drug. That sure sounds like the president, but let's examine the evidence.

Yesterday The Business Journals

Sangamo Therapeutics files for bankruptcy as Lilly and Astellas split assets

Sangamo Therapeutics Inc.'s assets will be split between Eli Lilly and Co. and Astellas Pharma Inc. and the longtime Bay Area biotech company has filed...

Never miss news about Lilly

Track Lilly and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Lilly competitors & trending companies

Browse news for competitors to Lilly and other trending companies.